2020 | 2021 | 2022 | 2023 | 2024 | |
---|---|---|---|---|---|
Revenue | $3.7B | $4B | $4.4B | $4.5B | $4.8B |
Cost of Revenue | $2.4B | $2.6B | $2.8B | $2.9B | $3.1B |
Gross Profit | $1.3B | $1.4B | $1.5B | $1.6B | $1.7B |
Gross Profit % | 35% | 36% | 35% | 35% | 35% |
R&D Expenses | $5.3M | $205K | $25M | $0 | $0 |
2020 | 2021 | 2022 | 2023 | 2024 | |
---|---|---|---|---|---|
Net Income | $308M | $369M | $353M | $631M | $514M |
Dep. & Amort. | $160M | $168M | $130M | $104M | $96M |
Def. Tax | -$23M | -$9.3M | -$29M | -$158M | $37M |
Stock Comp. | $74M | $82M | $77M | $89M | $66M |
Chg. in WC | $16M | $87M | -$147M | -$182M | -$100M |
2020 | 2021 | 2022 | 2023 | 2024 | |
---|---|---|---|---|---|
Cash | $680M | $899M | $647M | $584M | $648M |
ST Investments | $8.8M | $5.8M | $5.4M | $4.4M | $23M |
Cash & ST Inv. | $680M | $899M | $647M | $584M | $672M |
Receivables | $893M | $899M | $1B | $1.1B | $1.2B |
Inventory | $150M | $104M | $1 | $0 | $0 |
The company reported record-high operating results of €7.3 billion and an adjusted net result of €3.8 billion for FY 2024, driven by strong contributions across all business segments.
Life net inflows reached nearly €10 billion, with 71% of life reserves now tied to capital-light products. Property & Casualty gross written premiums grew by 7.7%, supported by tariff strengthening and improved combined ratios.
Asset and Wealth Management saw a 32% increase in total assets under management to €863 billion, with an operating result growth of nearly 23% to €1.2 billion.
The company announced a proposed dividend per share of €1.43 (up ~12% YoY) and a €500 million share buyback program, subject to regulatory approval, supported by a strong Solvency II ratio of 220%.
Looking ahead, the company remains focused on achieving its strategic targets for 2027, emphasizing sustainability, technical excellence, and profitable growth in key segments like protection, health, and accident insurance.